A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy

Temurhan S. , Akgul S. , Caliskan Y., Artan A. S. , Kekik Ç. , Yazici H. , ...More

TRANSPLANTATION PROCEEDINGS, vol.49, no.3, pp.541-545, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 49 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.1016/j.transproceed.2017.02.003
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.541-545


Background. The serum levels of galactose-deficient immunoglobulin (Ig)A1 (Gd-IgAl) represent the most promising candidate biomarker for IgA nephropathy (IgAN). The aim of this study was to evaluate the serum levels of Gd-IgAl as a novel noninvasive biomarker for post-transplant IgAN recurrence.